Australian Patent Issued for Trehalose (SLS-005) for Neurodegenerative Disorders
kaboompics / Pixabay

Australian Patent Issued for Trehalose (SLS-005) for Neurodegenerative Disorders

In a press release from late January 2021, biopharmaceutical company Seelos Therapeutics, Inc. ("Seelos") announced the issuance of an Australian patent for Trehalose (SLS-005). The patent (#2019204513) centers around the…

Continue Reading Australian Patent Issued for Trehalose (SLS-005) for Neurodegenerative Disorders